Add BrightSurf on Google Email

Monash University


New research shows AI can ask another AI for a second opinion on medical scans

Researchers at Monash University developed a co-training AI algorithm that can effectively mimic human oversight in medical imaging. The algorithm achieved an average improvement of 3% compared to state-of-the-art approaches using limited annotated data, enabling AI models to make more informed decisions and uncover accurate diagnoses.

SourceMonash University·JournalNature Machine Intelligence·TypeImaging analysis·DateJul 25, 2023

International migrants left behind in HIV response: study

A recent study found that international migrants in Australia are at increased risk of HIV infection due to reduced access to PrEP, a highly effective prevention measure. The study identified multiple barriers, including lack of awareness, low risk perception, and provider discrimination, which hinder their ability to access PrEP.

SourceMonash University·JournalThe Lancet Public Health·TypeSystematic review·DateJul 5, 2023

World's biggest study of wildfire smoke impact reveals alarming long-term health impacts

A comprehensive study found that increased exposure to wildfire-related PM2.5 was associated with a higher risk of all-cause and nonaccidental mortality, as well as an increased risk of dying from neoplasms. The research used a large-scale national cohort database from the UK Biobank, involving 492,394 participants.

SourceMonash University·JournalJournal of Hazardous Materials·TypeMeta-analysis·DateJun 21, 2023

Sustainability of a 12-month lifestyle intervention delivered by community health workers in reducing blood pressure in Nepal: 5-year follow-up of an open-label, cluster randomised (COBIN) trial

A 12-month lifestyle intervention led by community health workers reduced systolic blood pressure in Nepal. However, a 5-year follow-up found that the benefit was not maintained, with blood pressure rising again after the intervention ended. This highlights the need for ongoing education and follow-up to prevent potential harm.

SourceMonash University·JournalThe Lancet Global Health·TypeRandomized controlled/clinical trial·DateJun 20, 2023

Study shines new light on old drug for trauma care

A new study has found that the drug tranexamic acid significantly improves survival rates among severely injured patients, with approximately four extra survivors for every 100 treated with the medication. However, the long-term outcomes of care and quality of life remain a concern, highlighting the need for further research.

SourceMonash University·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateJun 14, 2023

Social media cherry blossom blooms and AI helping to track climate patterns

A recent study published in Flora used social media images of cherry blossoms to track climate patterns and identify subtle off-season blooms. The researchers analyzed 10 years of data from Flickr and compared it with official records of cherry flowering times in Japan, finding a detailed seasonal pattern of blooming across the country.

SourceMonash University·JournalFlora·TypeData/statistical analysis·DateJun 6, 2023

Making vaccines longer lasting

A recent study by Monash University researchers found that a unique subtype of an immune cell produces long-lasting antibodies in response to certain vaccinations. This discovery may lead to the development of improved vaccines providing life-long protection.

SourceMonash University·JournalImmunity·TypeExperimental study·DateMay 9, 2023

World first study into global daily air pollution shows almost nowhere on Earth is safe

A new study by Monash University found that almost nowhere on Earth is safe from air pollution, with only 0.001% of the global population exposed to safe levels of fine particulate matter (PM2.5). The study, which analyzed data from 2000-2019, revealed increasing pollution levels in Southern Asia, Australia, and Latin America.

SourceMonash University·JournalThe Lancet Planetary Health·TypeData/statistical analysis·DateMar 6, 2023

World first test to detect diabetics at risk of kidney disease

A world-first study has identified genetic markers for people with diabetes at risk of developing kidney disease. The findings could lead to the development of a predictive test that can detect adults with Type 1 diabetes at risk before symptoms appear, allowing for early-stage interventions.

SourceMonash University·JournalJournal of Clinical Investigation·TypeExperimental study·DateJan 13, 2023

Taking steps towards emissions reduction in healthcare

A recent study reviewed 3299 studies and found no standard tools for measuring the carbon footprint of digital health interventions globally. The researchers emphasize the need for end-to-end systems-based environmental assessments to encourage greener digital healthcare solutions.

SourceMonash University·JournalJournal of the American Medical Informatics Association·TypeSystematic review·DateOct 31, 2022

Kidney health in adult life begins in the womb, Monash University researchers discover

Researchers found that human kidneys with more blood filters (glomeruli) contained more podocytes per filter. This means that people with more glomeruli not only have more units of podocytes overall, but these cells are more concentrated in each filter. Early discoveries suggest expectant mothers can reduce their babies' future kidney ...

SourceMonash University·JournalKidney International·TypeExperimental study·DateOct 13, 2022

Discovery opens way to develop new immunotherapies

Australian researchers have discovered a new mechanism by which T cells can react to lower doses of antigens, leading to a 50-fold increase in T cell activation sensitivity. This finding opens up new possibilities for developing more effective immunotherapies.

SourceMonash University·JournalNature Communications·TypeExperimental study·DateAug 24, 2022

Potential target for Type 1 diabetes treatment

Researchers at Monash University have discovered a new pathway to regenerate insulin in pancreatic stem cells, which could lead to new therapies for Type 1 and Type 2 diabetes. The study uses a drug approved by the US FDA to reactivate dormant insulin-producing cells, paving the way for potential treatments.

SourceMonash University·JournalSignal Transduction and Targeted Therapy·TypeExperimental study·DateJul 21, 2022

Promising treatment for dementia

A clinical trial found that sodium selenate stabilizes escalating behavioural issues and slows brain shrinkage in patients with behavioural variant frontotemporal dementia. The treatment has been shown to be safe and well-tolerated, with reduced rates of cognitive and behavioural symptoms.

SourceMonash University·JournalAlzheimer s & Dementia Translational Research & Clinical Interventions·TypeRandomized controlled/clinical trial·DateMay 5, 2022

A unique study finds that tick saliva may offer a path to new therapies for inflammatory diseases

A recent study by Monash University found that tick saliva proteins, called evasins, can be modified to block the activity of important proteins in human inflammatory diseases. The study identified the structural basis of chemokine recognition and establishes a foundation for engineering evasins.

SourceMonash University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateFeb 21, 2022

Unconventional T cells promote immunity to malaria

A new study reveals that gamma delta T cells play a critical role in promoting clinical protection against malaria. The unique T cell receptor on these cells enables them to recognize and tolerate Plasmodium falciparum parasite fragments, providing a vital component of an effective immune response.

SourceMonash University·JournalScience Translational Medicine·DateDec 1, 2021

How T cells recognize infection or disease

Researchers at Monash University have discovered how gamma delta T cells recognize the MHC-like molecule MR1, providing key insights into the immune system's ability to detect infections and diseases. The study sheds light on the unique ways these cells interact with MR1, paving the way for new immunotherapies.

SourceMonash University·JournalProceedings of the National Academy of Sciences·TypeObservational study·DateNov 29, 2021

Monash University study uncovers a new understanding of how mesenchymal stromal cells benefit patients in cell therapy

Researchers found that the therapeutic effects of MSCs are due to the recipient's immune cells responding to dying MSCs undergoing apoptosis, promoting anti-inflammatory effects. This understanding may lead to new therapeutic strategies targeting the responding immune cell population.

SourceMonash University·JournalNature Communications·TypeExperimental study·DateNov 11, 2021

Study of 18000+ US and Australian older people reveals moderate drinking protective against heart disease, more than for tea totalers

A landmark Monash University study found moderate drinking is associated with a reduced risk of cardiovascular disease and mortality in healthy older adults. The study of over 18,000 participants aged 70+ found that consumption of 51-100 g/week was linked to lower CVD event risks and all-cause mortality.

SourceMonash University·JournalEuropean Journal of Preventive Cardiology·TypeRandomized controlled/clinical trial·DateNov 5, 2021